Literature DB >> 2835510

The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation.

P J Dolph1, V Racaniello, A Villamarin, F Palladino, R J Schneider.   

Abstract

The adenovirus tripartite leader is a 200-nucleotide 5' noncoding region that is found on all late viral mRNAs. This segment is required for preferential translation of viral mRNAs at late times during infection. Most tripartite leader-containing mRNAs appear to exhibit little if any requirement for intact cap-binding protein complex, a property previously established only for uncapped poliovirus mRNAs and capped mRNAs with minimal secondary structure. The tripartite leader also permits the translation of mRNAs in poliovirus-infected cells in the apparent absence of active cap-binding protein complex and does not require any adenovirus gene products for this activity. The preferential translation of viral late mRNAs may involve this unusual property.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835510      PMCID: PMC253291          DOI: 10.1128/JVI.62.6.2059-2066.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.

Authors:  N Sonenberg; D Guertin; K A Lee
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

2.  Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

Authors:  G A Beltz; S J Flint
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

3.  Comparison of initiation rates of encephalomyocarditis virus and host protein synthesis in infected cells.

Authors:  G Jen; C H Birge; R E Thach
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

4.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

5.  Adenovirus-2 messengers--an example of baroque molecular architecture.

Authors:  T R Broker; L T Chow; A R Dunn; R E Gelinas; J A Hassell; D F Klessig; J B Lewis; R J Roberts; B S Zain
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

6.  Adenovirus polypeptide synthesis in the presence of non-replicating poliovirus.

Authors:  R Bablanian; W C Russell
Journal:  J Gen Virol       Date:  1974-08       Impact factor: 3.891

7.  Cellular protein synthesis shutoff by mengovirus: translation of nonviral and viral mRNA's in extracts from uninfected and infected Ehrlich ascites tumor cells.

Authors:  S L Abreu; J Lucas-Lenard
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

8.  Inhibition of transcription factor activity by poliovirus.

Authors:  N Crawford; A Fire; M Samuels; P A Sharp; D Baltimore
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

9.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

10.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  41 in total

1.  p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

Authors:  J N Harada; A J Berk
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F.

Authors:  R Cuesta; Q Xi; R J Schneider
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray.

Authors:  G Johannes; M S Carter; M B Eisen; P O Brown; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters.

Authors:  L Kwee; R Lucito; B Aufiero; R J Schneider
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs.

Authors:  Qiaoran Xi; Rafael Cuesta; Robert J Schneider
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.

Authors:  P J Dolph; J T Huang; R J Schneider
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein.

Authors:  D Riley; S J Flint
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation.

Authors:  D Feigenblum; R J Schneider
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation.

Authors:  N Fouillot; S Tlouzeau; J M Rossignol; O Jean-Jean
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells.

Authors:  U C Yang; W Huang; S J Flint
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.